Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal models

Several COVID-19 vaccines, some more efficacious than others, are now available and deployed, including multiple mRNA- and viral vector-based vaccines. With the focus on creating cost-effective solutions that can reach the low- and medium- income world, GreenLight Biosciences has developed an mRNA v...

Descripción completa

Detalles Bibliográficos
Autores principales: Lelis, Felipe, Byk, Laura A., Pustylnikov, Sergei, Nguyen, Vivian, Nguyen, Brandon, Nitz, Malorie, Tarte, Prutha, Tungare, Kunal, Li, Jilong, Manna, Saikat, Maiti, Sampa, Mehta, Dhwani H., Sekar, Narendran, Posadas, Diana M., Dhamankar, Himanshu, Hughes, Jeffrey A., Aulisa, Lorenzo, Khan, Amin, Melo, Mariane B., Dey, Antu K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692331/
https://www.ncbi.nlm.nih.gov/pubmed/38040905
http://dx.doi.org/10.1038/s41598-023-46233-6

Ejemplares similares

Ejemplares similares